Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Zinner

Showing results (71-80 of 74) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 74 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 30, 2005
Natural history of rising serum prostate-specific antigen in men with castrate nonmetastatic prostate cancerMatthew R Smith, Fairooz Kabbinavar, Fred Saad, et al.
Seminars in Radiation Oncology|March 28, 2002
Randomized phase III study of chemoradiation with or without amifostine for patients with favorable performance status inoperable stage II-III non-small cell lung cancer: preliminary resultsR Komaki, J S Lee, B Kaplan, et al.
ESMO Open|February 17, 2026
Fast Real-Time Assessment of Combination Therapies in Immuno-ONcology in patients with advanced non-small-cell lung cancer (FRACTION-Lung)K He, P M Forde, R Govindan, et al.
BMC Cancer|October 18, 2015
Retreatment with anti-EGFR based therapies in metastatic colorectal cancer: impact of intervening time interval and prior anti-EGFR responseX Liu, G C George, A M Tsimberidou, et al.
Pageof 8

Showing results (71-80 of 74) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 74 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 30, 2005
Natural history of rising serum prostate-specific antigen in men with castrate nonmetastatic prostate cancerMatthew R Smith, Fairooz Kabbinavar, Fred Saad, et al.
Seminars in Radiation Oncology|March 28, 2002
Randomized phase III study of chemoradiation with or without amifostine for patients with favorable performance status inoperable stage II-III non-small cell lung cancer: preliminary resultsR Komaki, J S Lee, B Kaplan, et al.
ESMO Open|February 17, 2026
Fast Real-Time Assessment of Combination Therapies in Immuno-ONcology in patients with advanced non-small-cell lung cancer (FRACTION-Lung)K He, P M Forde, R Govindan, et al.
BMC Cancer|October 18, 2015
Retreatment with anti-EGFR based therapies in metastatic colorectal cancer: impact of intervening time interval and prior anti-EGFR responseX Liu, G C George, A M Tsimberidou, et al.
Pageof 8